ZymoGenetics

THERAPEUTIC AREAS

Viral Disease
- PEG-Interferon lambda
Immunology
- IL-31 mAb
Oncology
- IL-21
Surgical Bleeding

Aug 25, 2010 - ZymoGenetics Announces Completion of Enrollment in Phase 2b Clinical Trial with PEG-Interferon lambda in Hepatitis C
Aug 4, 2010 - ZymoGenetics to Webcast Presentation at the Canaccord Annual Growth Conference
Aug 3, 2010 - ZymoGenetics Reports Second Quarter 2010 Financial Results

News Archive »

Replay
ZymoGenetics Inc. at Canaccord Adams Global Growth Conference
August 10, 2010 at 8:30 a.m. ET
Replay
Q2 2010 ZymoGenetics Inc. Earnings Conference Call
August 03, 2010 at 4:30 p.m. ET

Events Archive »

CORPORATE RESOURCES